View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 30, 2021updated 12 Jul 2022 11:21am

Formedix unveils Cloud-based platform for clinical trials

Clinical trial software solutions provider Formedix has launched a new all-in-one Cloud-based clinical metadata repository (MDR) and study automation platform called ryze.

Clinical trial software solutions provider Formedix has launched a new all-in-one Cloud-based clinical metadata repository (MDR) and study automation platform called ryze.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The company has developed ryze to expedite and streamline the design, build and submission of clinical trials, in compliance with the Clinical Data Interchange Standards Consortium (CDISC) and NCI Controlled Terminology.

The platform, which automates SDTM mappings and conversions, enables the design and build of the full spectrum of case report forms (CRFs), study data tabulation models (SDTMs) and analysis data models (ADaMs).

It is a fully-integrated software suite and features metadata templates with embedded CDISC standards and NCI Controlled Terminology that enables pharmaceutical, biotechnology and CRO organisations to meet their regulatory objectives.

The platform also facilitates metadata standardisation, accelerating clinical trial set up, enabling data reuse, and improving data quality and consistency.

Formedix Product Management head Kevin Burges said: “As an all-in-one Cloud-based platform, ryze simplifies end-to-end metadata management and fosters cross-collaboration between stakeholders.

“Ultimately, the platform provides significant time and cost savings, facilitating faster delivery of new therapies.”

It also allows integration with a range of electronic data capture (EDC) systems, including support for the individual functionality of each system.

Clinical data professionals can design CRFs using ryze and make any necessary changes prior to exporting the designs into the EDC of their choice automatically to build their clinical trial.

The commercial off-the-shelf system is available for immediate use and can be configured to meet specific application needs.

SDTM conversion is enabled at the click of a button and provides instant visibility of patient data to clinicians immediately after it starts flowing in from the EDC system.

With this, clinicians can gain actionable data insights to drive data-based decision making.

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena